Clinical trials for stem cell therapies
2011
Clinical Trials for Stem Cell Therapies
publication
Evidence: moderate
Author Information
Author(s): Alan Trounson, Rahul G. Thakar, Geoff Lomax, Don Gibbons
Primary Institution: California Institute for Regenerative Medicine
Conclusion
Clinical trials on the use of stem cells are underway for a wide variety of conditions, showing safety but inconsistent long-term benefits.
Supporting Evidence
- Clinical trials are exploring the use of various types of stem cells for treating diseases.
- Safety has been consistently demonstrated, particularly with autologous transplants.
- There is a need for more research to determine the long-term benefits of stem cell therapies.
Takeaway
Scientists are testing stem cells to help heal different diseases, but while they are generally safe, they don't always work as well as hoped.
Limitations
Sustained curative benefits have not been consistently obtained, and allogenic transplants have major issues with immunosuppression.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website